Malaria chemoprophylaxis with mefloquine
Identifieur interne : 000B79 ( Istex/Corpus ); précédent : 000B78; suivant : 000B80Malaria chemoprophylaxis with mefloquine
Auteurs : Anders Björkman ; Robert Steffen ; Maxime Armengaud ; Nicole Picot ; Sylvie PiccoliSource :
- The Lancet [ 0140-6736 ] ; 1991.
English descriptors
- Teeft :
- Adverse reactions, Carcinoma, Chemoprophylaxis, Chloroquine, Direct preparation, Disease gene, East africa, European tourists, Genet, Incision, Infectious diseases, Ligation, Maher, Malaria, Malaria chemoprophylaxis, Medial aspect, Mefloquine, Perforator, Perforator veins, Phaeochromocytoma, Posterior compartment, Proguanil, Prophylaxis, Protective efficacy, Psychosis, Randomised trial, Regimen, Renal, Renal cell carcinoma, Renal cysts, Small region, Surg, Traveller, Tropical africa, West africa, World health organisation, Yates.
Url:
DOI: 10.1016/0140-6736(91)93168-9
Links to Exploration step
ISTEX:B3524553DAC11308E50B8612D6A4FBDF91422AC4Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Malaria chemoprophylaxis with mefloquine</title><author><name sortKey="Bjorkman, Anders" sort="Bjorkman, Anders" uniqKey="Bjorkman A" first="Anders" last="Björkman">Anders Björkman</name><affiliation><mods:affiliation>Department of Infectious Diseases, Roslagstull Hospital, S-114 89 Stockholm, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Steffen, Robert" sort="Steffen, Robert" uniqKey="Steffen R" first="Robert" last="Steffen">Robert Steffen</name><affiliation><mods:affiliation>Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland</mods:affiliation></affiliation></author><author><name sortKey="Armengaud, Maxime" sort="Armengaud, Maxime" uniqKey="Armengaud M" first="Maxime" last="Armengaud">Maxime Armengaud</name><affiliation><mods:affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</mods:affiliation></affiliation></author><author><name sortKey="Picot, Nicole" sort="Picot, Nicole" uniqKey="Picot N" first="Nicole" last="Picot">Nicole Picot</name><affiliation><mods:affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</mods:affiliation></affiliation></author><author><name sortKey="Piccoli, Sylvie" sort="Piccoli, Sylvie" uniqKey="Piccoli S" first="Sylvie" last="Piccoli">Sylvie Piccoli</name><affiliation><mods:affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B3524553DAC11308E50B8612D6A4FBDF91422AC4</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1016/0140-6736(91)93168-9</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-JK89DQD9-9/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000B79</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B79</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Malaria chemoprophylaxis with mefloquine</title><author><name sortKey="Bjorkman, Anders" sort="Bjorkman, Anders" uniqKey="Bjorkman A" first="Anders" last="Björkman">Anders Björkman</name><affiliation><mods:affiliation>Department of Infectious Diseases, Roslagstull Hospital, S-114 89 Stockholm, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Steffen, Robert" sort="Steffen, Robert" uniqKey="Steffen R" first="Robert" last="Steffen">Robert Steffen</name><affiliation><mods:affiliation>Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland</mods:affiliation></affiliation></author><author><name sortKey="Armengaud, Maxime" sort="Armengaud, Maxime" uniqKey="Armengaud M" first="Maxime" last="Armengaud">Maxime Armengaud</name><affiliation><mods:affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</mods:affiliation></affiliation></author><author><name sortKey="Picot, Nicole" sort="Picot, Nicole" uniqKey="Picot N" first="Nicole" last="Picot">Nicole Picot</name><affiliation><mods:affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</mods:affiliation></affiliation></author><author><name sortKey="Piccoli, Sylvie" sort="Piccoli, Sylvie" uniqKey="Piccoli S" first="Sylvie" last="Piccoli">Sylvie Piccoli</name><affiliation><mods:affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">The Lancet</title><title level="j" type="abbrev">LANCET</title><idno type="ISSN">0140-6736</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1991">1991</date><biblScope unit="volume">337</biblScope><biblScope unit="issue">8755</biblScope><biblScope unit="page" from="1479">1479</biblScope><biblScope unit="page" to="1480">1480</biblScope></imprint><idno type="ISSN">0140-6736</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0140-6736</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adverse reactions</term><term>Carcinoma</term><term>Chemoprophylaxis</term><term>Chloroquine</term><term>Direct preparation</term><term>Disease gene</term><term>East africa</term><term>European tourists</term><term>Genet</term><term>Incision</term><term>Infectious diseases</term><term>Ligation</term><term>Maher</term><term>Malaria</term><term>Malaria chemoprophylaxis</term><term>Medial aspect</term><term>Mefloquine</term><term>Perforator</term><term>Perforator veins</term><term>Phaeochromocytoma</term><term>Posterior compartment</term><term>Proguanil</term><term>Prophylaxis</term><term>Protective efficacy</term><term>Psychosis</term><term>Randomised trial</term><term>Regimen</term><term>Renal</term><term>Renal cell carcinoma</term><term>Renal cysts</term><term>Small region</term><term>Surg</term><term>Traveller</term><term>Tropical africa</term><term>West africa</term><term>World health organisation</term><term>Yates</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>elsevier</corpusName><keywords><teeft><json:string>mefloquine</json:string><json:string>chemoprophylaxis</json:string><json:string>chloroquine</json:string><json:string>perforator</json:string><json:string>maher</json:string><json:string>phaeochromocytoma</json:string><json:string>psychosis</json:string><json:string>surg</json:string><json:string>incision</json:string><json:string>genet</json:string><json:string>yates</json:string><json:string>ligation</json:string><json:string>prophylaxis</json:string><json:string>renal cell carcinoma</json:string><json:string>proguanil</json:string><json:string>renal</json:string><json:string>east africa</json:string><json:string>infectious diseases</json:string><json:string>regimen</json:string><json:string>medial aspect</json:string><json:string>adverse reactions</json:string><json:string>west africa</json:string><json:string>tropical africa</json:string><json:string>european tourists</json:string><json:string>randomised trial</json:string><json:string>world health organisation</json:string><json:string>malaria chemoprophylaxis</json:string><json:string>renal cysts</json:string><json:string>protective efficacy</json:string><json:string>perforator veins</json:string><json:string>posterior compartment</json:string><json:string>small region</json:string><json:string>disease gene</json:string><json:string>direct preparation</json:string><json:string>carcinoma</json:string><json:string>malaria</json:string><json:string>traveller</json:string></teeft></keywords><author><json:item><name>Anders Björkman</name><affiliations><json:string>Department of Infectious Diseases, Roslagstull Hospital, S-114 89 Stockholm, Sweden</json:string></affiliations></json:item><json:item><name>Robert Steffen</name><affiliations><json:string>Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland</json:string></affiliations></json:item><json:item><name>Maxime Armengaud</name><affiliations><json:string>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</json:string></affiliations></json:item><json:item><name>Nicole Picot</name><affiliations><json:string>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</json:string></affiliations></json:item><json:item><name>Sylvie Piccoli</name><affiliations><json:string>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</json:string></affiliations></json:item></author><arkIstex>ark:/67375/6H6-JK89DQD9-9</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>Correspondence</json:string></originalGenre><qualityIndicators><score>4.081</score><pdfWordCount>2069</pdfWordCount><pdfCharCount>13454</pdfCharCount><pdfVersion>1.2</pdfVersion><pdfPageCount>2</pdfPageCount><pdfPageSize>622 x 969 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>1</abstractWordCount><abstractCharCount>0</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Malaria chemoprophylaxis with mefloquine</title><pmid><json:string>1675342</json:string></pmid><pii><json:string>0140-6736(91)93168-9</json:string></pii><genre><json:string>other</json:string></genre><host><title>The Lancet</title><language><json:string>unknown</json:string></language><publicationDate>1991</publicationDate><issn><json:string>0140-6736</json:string></issn><pii><json:string>S0140-6736(00)X4931-8</json:string></pii><volume>337</volume><issue>8755</issue><pages><first>1479</first><last>1480</last></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>1991</json:string></date><geogName></geogName><orgName><json:string>WHO</json:string><json:string>Switzerland ROBERT STEFFEN Infectious Diseases Clinic, CHU Purpan, Toulouse, France MAXIME ARMENGAUD NICOLE PICOT SYLVIE PICCOLI BJ</json:string><json:string>Sweden ANDERS Institute of Social and Preventive Medicine</json:string><json:string>University of Zurich</json:string><json:string>Contiguous Institute of Human Genetics, University Hospital</json:string><json:string>and US Centers for Disease Control</json:string><json:string>Department of Surgery, University of Oporto, Grupo</json:string><json:string>Department of Infectious Diseases, Roslagstull Hospital</json:string><json:string>Malaria Germany ULRICH LANGENBECK Cytogenet Cell Genet</json:string><json:string>East Africa International Congress for Infectious Diseases</json:string><json:string>World Health Organisation</json:string><json:string>International Congress</json:string><json:string>CDC</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Ann Surg</json:string><json:string>Petersen</json:string><json:string>M. Recurrences</json:string><json:string>Lilford</json:string><json:string>G. Eme</json:string><json:string>Von Hippel</json:string><json:string>Neumann</json:string><json:string>Fetersen</json:string><json:string>Dr</json:string><json:string>Wiestler</json:string></persName><placeName><json:string>Lindau</json:string><json:string>Frankfurt/Main</json:string><json:string>Porto</json:string><json:string>Portugal</json:string><json:string>Stockholm</json:string><json:string>Zurich</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Lilford et al</json:string><json:string>WHO, 1989</json:string><json:string>Green et al</json:string><json:string>Montreal, 1990</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/6H6-JK89DQD9-9</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - medicine, general & internal</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - general & internal medicine</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string></scopus></categories><publicationDate>1991</publicationDate><copyrightDate>1991</copyrightDate><doi><json:string>10.1016/0140-6736(91)93168-9</json:string></doi><id>B3524553DAC11308E50B8612D6A4FBDF91422AC4</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-JK89DQD9-9/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-JK89DQD9-9/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-JK89DQD9-9/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a">Malaria chemoprophylaxis with mefloquine</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher><availability><licence><p>elsevier</p></licence></availability><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p><date>1991</date></publicationStmt><notesStmt><note type="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note type="content">Section title: LETTERS to the EDITOR</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Malaria chemoprophylaxis with mefloquine</title><author xml:id="author-0000"><persName><forename type="first">Anders</forename><surname>Björkman</surname></persName><affiliation>Department of Infectious Diseases, Roslagstull Hospital, S-114 89 Stockholm, Sweden</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Robert</forename><surname>Steffen</surname></persName><affiliation>Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland</affiliation></author><author xml:id="author-0002"><persName><forename type="first">Maxime</forename><surname>Armengaud</surname></persName><affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</affiliation></author><author xml:id="author-0003"><persName><forename type="first">Nicole</forename><surname>Picot</surname></persName><affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</affiliation></author><author xml:id="author-0004"><persName><forename type="first">Sylvie</forename><surname>Piccoli</surname></persName><affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</affiliation></author><idno type="istex">B3524553DAC11308E50B8612D6A4FBDF91422AC4</idno><idno type="ark">ark:/67375/6H6-JK89DQD9-9</idno><idno type="DOI">10.1016/0140-6736(91)93168-9</idno><idno type="PII">0140-6736(91)93168-9</idno></analytic><monogr><title level="j">The Lancet</title><title level="j" type="abbrev">LANCET</title><idno type="pISSN">0140-6736</idno><idno type="PII">S0140-6736(00)X4931-8</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1991"></date><biblScope unit="volume">337</biblScope><biblScope unit="issue">8755</biblScope><biblScope unit="page" from="1479">1479</biblScope><biblScope unit="page" to="1480">1480</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1991</date></creation><langUsage><language ident="en">en</language></langUsage></profileDesc><revisionDesc><change when="1991">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-JK89DQD9-9/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="cor"><item-info><jid>LANCET</jid><aid>91931689</aid><ce:pii>0140-6736(91)93168-9</ce:pii><ce:doi>10.1016/0140-6736(91)93168-9</ce:doi><ce:copyright type="unknown" year="1991"></ce:copyright></item-info><head><ce:dochead><ce:textfn>LETTERS to the EDITOR</ce:textfn></ce:dochead><ce:title>Malaria chemoprophylaxis with mefloquine</ce:title><ce:author-group><ce:author><ce:given-name>Anders</ce:given-name><ce:surname>Björkman</ce:surname><ce:cross-ref refid="ART45-AFF1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Robert</ce:given-name><ce:surname>Steffen</ce:surname><ce:cross-ref refid="ART45-AFF2"><ce:sup>b</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Maxime</ce:given-name><ce:surname>Armengaud</ce:surname><ce:cross-ref refid="ART45-AFF3"><ce:sup>c</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Nicole</ce:given-name><ce:surname>Picot</ce:surname><ce:cross-ref refid="ART45-AFF3"><ce:sup>c</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Sylvie</ce:given-name><ce:surname>Piccoli</ce:surname><ce:cross-ref refid="ART45-AFF3"><ce:sup>c</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="ART45-AFF1"><ce:label>a</ce:label><ce:textfn>Department of Infectious Diseases, Roslagstull Hospital, S-114 89 Stockholm, Sweden</ce:textfn></ce:affiliation><ce:affiliation id="ART45-AFF2"><ce:label>b</ce:label><ce:textfn>Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland</ce:textfn></ce:affiliation><ce:affiliation id="ART45-AFF3"><ce:label>c</ce:label><ce:textfn>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</ce:textfn></ce:affiliation></ce:author-group></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Malaria chemoprophylaxis with mefloquine</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Malaria chemoprophylaxis with mefloquine</title></titleInfo><name type="personal"><namePart type="given">Anders</namePart><namePart type="family">Björkman</namePart><affiliation>Department of Infectious Diseases, Roslagstull Hospital, S-114 89 Stockholm, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Robert</namePart><namePart type="family">Steffen</namePart><affiliation>Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Maxime</namePart><namePart type="family">Armengaud</namePart><affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Nicole</namePart><namePart type="family">Picot</namePart><affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sylvie</namePart><namePart type="family">Piccoli</namePart><affiliation>Infectious Diseases Clinic, CHU Purpan, Toulouse, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="Correspondence" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1991</dateIssued><copyrightDate encoding="w3cdtf">1991</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><note type="content">Section title: LETTERS to the EDITOR</note><relatedItem type="host"><titleInfo><title>The Lancet</title></titleInfo><titleInfo type="abbreviated"><title>LANCET</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1991</dateIssued></originInfo><identifier type="ISSN">0140-6736</identifier><identifier type="PII">S0140-6736(00)X4931-8</identifier><part><date>1991</date><detail type="issue"><title>Originally published as Volume 1, Issue 8755</title></detail><detail type="volume"><number>337</number><caption>vol.</caption></detail><detail type="issue"><number>8755</number><caption>no.</caption></detail><extent unit="issue-pages"><start>1427</start><end>1490</end></extent><extent unit="pages"><start>1479</start><end>1480</end></extent></part></relatedItem><identifier type="istex">B3524553DAC11308E50B8612D6A4FBDF91422AC4</identifier><identifier type="ark">ark:/67375/6H6-JK89DQD9-9</identifier><identifier type="DOI">10.1016/0140-6736(91)93168-9</identifier><identifier type="PII">0140-6736(91)93168-9</identifier><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-JK89DQD9-9/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B79 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B79 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:B3524553DAC11308E50B8612D6A4FBDF91422AC4
|texte= Malaria chemoprophylaxis with mefloquine
}}
| This area was generated with Dilib version V0.6.33. |  |